Ursprung des Netzwerks ersten Grades von Ru Shu Luo
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
OncoImmune, Inc.
 OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ru Shu Luo
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Oncoc4, Inc. | Founder Chief Operating Officer | ||
| Seattle University | College/University | Masters Business Admin | |
| Dartmouth College | College/University | Doctorate Degree | |
| Denison University | College/University | Undergraduate Degree | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Corporate Officer/Principal | |
EpicentRx, Inc.
 EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Rise Therapeutics LLC
 Rise Therapeutics LLC BiotechnologyHealth Technology Rise Therapeutics LLC develops immunological-based biologics using proprietary oral delivery platform. It offers drugs for the treatment of inflammation, autoimmunity, and cancer. The company was founded by Gary Fanger and Neil Fanger on September 4, 2014 and is headquartered in Rockville, MD. | Biotechnology | Chief Executive Officer | |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
Avirmax, Inc.
 Avirmax, Inc. Miscellaneous Commercial ServicesCommercial Services Avirmax, Inc. is a biotechnology company. The company is headquartered in Hayward, CA. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 11 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 7 |
| Founder | 5 |
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 3 |
| Chief Executive Officer | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Gary Fanger | 8 |
| Yang Liu | 2 |
| Pan Zheng | 2 |
| Qian Ye Liu | 2 |
| Martin Devenport | 2 |
| Kun-Liang Guan | 1 |
| Miao Hong | 1 |
- Börse
- Insiders
- Ru Shu Luo
- Unternehmensverbindungen
